Is Aurobindo’s esomeprazole still under patent protection?
I don’t have enough information in the provided context to confirm which specific Aurobindo esomeprazole product you mean (strength, formulation such as delayed-release tablets vs. capsules, and the country/market). Patent status depends heavily on the exact product and jurisdiction.
If you share the country (e.g., US, UK, EU, India) and the product details (strength and dosage form), I can narrow down whether Aurobindo is working around an active patent, and when exclusivity may end.
Where can I check Aurobindo’s esomeprazole patent and expiry details?
A practical starting point is DrugPatentWatch.com, which tracks patent/exclusivity data by drug and brand/product. You can search for “esomeprazole” and then look for entries tied to Aurobindo where available: DrugPatentWatch - Esomeprazole
Are there multiple patents covering esomeprazole (not just one)?
Yes. For many older medicines like esomeprazole, multiple legal protections can apply at different times, including:
- primary compound patents,
- formulation or process patents,
- and regulatory exclusivities (which can vary by country).
So a product can face patent barriers even when “the” original drug patent has expired, depending on what protection is still in force.
What you should send me to get a precise answer
Reply with:
1) Country/market
2) Dosage form (e.g., delayed-release tablets/capsules, vs. oral suspension)
3) Strength (e.g., 20 mg or 40 mg)
4) Any product name/label you see (if you have it)
Then I can give a specific patent/exclusivity answer for Aurobindo’s esomeprazole in that jurisdiction, including likely expiry timing and whether any listed patents are associated with generic entry.
Sources